Back to Search
DESIREE PALMER, DMD
DMD
General Practice Dentistry
NPI: 1285746966Individual
Specialties, Licenses & Credentials
Research & Publications (20)
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.
PMID 18980227·Hepatology·2009
3-trial
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity.
PMID 18523011·Proc Natl Acad Sci U S A·2008
7-preclinical
A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin.
PMID 17453298·Ann Surg Oncol·2007
3-trial
Human colostrum: identification of minor proteins in the aqueous phase by proteomics.
PMID 16502470·Proteomics·2006
4-observational
Gib2, a novel Gbeta-like/RACK1 homolog, functions as a Gbeta subunit in cAMP signaling and is essential in Cryptococcus neoformans.
PMID 16950773·J Biol Chem·2006
8-other
Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.
PMID 15800660·Gene Ther·2005
8-other
Gene- and immunotherapy for hepatocellular carcinoma.
PMID 15934829·Expert Opin Biol Ther·2005
6-review
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction.
PMID 15585842·J Immunol·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 105 NEWSOM ST, SUITE 204
DURHAM, NC 27704 - Phone
- (919) 471-9106
Quick Facts
- NPI
- 1285746966
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile